Infinity Pharmaceuticals Inc has a consensus price target of $4.83 based on the ratings of 4 analysts. The high is $9 issued by HC Wainwright & Co. on October 18, 2021. The low is $1.5 issued by B. Riley Securities on November 16, 2022. The 3 most-recent analyst ratings were released by B. Riley Securities, Piper Sandler, and Truist Securities on November 16, 2022, May 23, 2022, and March 31, 2022, respectively. With an average price target of $2.83 between B. Riley Securities, Piper Sandler, and Truist Securities, there's an implied 12605.53% upside for Infinity Pharmaceuticals Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Infinity Pharmaceuticals Inc (OTC:INFI) was reported by Piper Sandler on February 24, 2023. The analyst firm set a price target for $0.00 expecting INFI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Infinity Pharmaceuticals Inc (OTC:INFI) was provided by Piper Sandler, and Infinity Pharmaceuticals Inc downgraded their neutral rating.
There is no last upgrade for Infinity Pharmaceuticals Inc
The last downgrade for Infinity Pharmaceuticals Inc happened on February 24, 2023 when Piper Sandler changed their price target from N/A to N/A for Infinity Pharmaceuticals Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Infinity Pharmaceuticals Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Infinity Pharmaceuticals Inc was filed on February 24, 2023 so you should expect the next rating to be made available sometime around February 24, 2024.
While ratings are subjective and will change, the latest Infinity Pharmaceuticals Inc (INFI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Infinity Pharmaceuticals Inc (INFI) is trading at is $0.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.